Premium
“Epigenetic” modification as therapy for acute myeloid leukemia
Author(s) -
Schiffer Charles A.
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31137
Subject(s) - medicine , myeloid leukemia , epigenetics , myeloid , leukemia , epigenesis , cancer research , bioinformatics , oncology , immunology , dna methylation , genetics , gene , biology , gene expression
The benefits and limitations of the treatment of acute myeloid leukemia/myelodysplasia with epigenetic modifiers are discussed. See also pages 325‐34.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom